Combination therapy to checkmate Glioblastoma: clinical challenges and advances D Ghosh, S Nandi, S Bhattacharjee Clinical and translational medicine 7 (1), 33, 2018 | 201 | 2018 |
Dicer promotes transcription termination at sites of replication stress to maintain genome stability SE Castel, J Ren, S Bhattacharjee, AY Chang, M Sánchez, A Valbuena, ... Cell 159 (3), 572-583, 2014 | 120 | 2014 |
DNA damage response and cancer therapeutics through the lens of the Fanconi Anemia DNA repair pathway S Bhattacharjee, S Nandi Cell Communication and Signaling 15, 1-10, 2017 | 85 | 2017 |
Choices have consequences: the nexus between DNA repair pathways and genomic instability in cancer S Bhattacharjee, S Nandi Clinical and translational medicine 5, 1-8, 2016 | 84 | 2016 |
CRISPR–Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics D Ghosh, P Venkataramani, S Nandi, S Bhattacharjee Cancer cell international 19, 1-10, 2019 | 77 | 2019 |
Synthetic lethality in DNA repair network: A novel avenue in targeted cancer therapy and combination therapeutics S Bhattacharjee, S Nandi Iubmb Life 69 (12), 929-937, 2017 | 72 | 2017 |
Transcription factors that govern development and disease: an achilles heel in cancer D Huilgol, P Venkataramani, S Nandi, S Bhattacharjee Genes 10 (10), 794, 2019 | 59 | 2019 |
Rare genetic diseases with defects in DNA repair: opportunities and challenges in orphan drug development for targeted cancer therapy S Bhattacharjee, S Nandi Cancers 10 (9), 298, 2018 | 45 | 2018 |
Impact of detergents on membrane protein complex isolation YC Lee, JA Bååth, RM Bastle, S Bhattacharjee, MJ Cantoria, ... Journal of proteome research 17 (1), 348-358, 2018 | 35 | 2018 |
MHF1–2/CENP-SX performs distinct roles in centromere metabolism and genetic recombination S Bhattacharjee, F Osman, L Feeney, A Lorenz, C Bryer, MC Whitby Open Biology 3 (9), 130102, 2013 | 34 | 2013 |
RNA-induced initiation of transcriptional silencing (RITS) complex structure and function S Bhattacharjee, B Roche, RA Martienssen RNA biology 16 (9), 1133-1146, 2019 | 32 | 2019 |
Hallmarks of splicing defects in cancer: clinical applications in the era of personalized medicine MA Rahman, F Nasrin, S Bhattacharjee, S Nandi Cancers 12 (6), 1381, 2020 | 21 | 2020 |
Chromatin remodeling of histone H3 variants by DDM1 underlies epigenetic inheritance of DNA methylation SC Lee, DW Adams, JJ Ipsaro, J Cahn, J Lynn, HS Kim, B Berube, ... Cell 186 (19), 4100-4116. e15, 2023 | 17 | 2023 |
Combination therapy to checkmate Glioblastoma: clinical challenges and advances. Clin Transl Med. 2018; 7 (1): 33 D Ghosh, S Nandi, S Bhattacharjee Epub 2018/10/18. doi: 10.1186/s40169-018-0211-8. PubMed PMID: 30327965, 0 | 4 | |
Combination therapy to checkmate Glioblastoma: clinical challenges and advances. Clin Transl Med. 2018; 7: 33 D Ghosh, S Nandi, S Bhattacharjee | 4 | |
Chromatin remodeling of histone H3 variants underlies epigenetic inheritance of DNA methylation SC Lee, DW Adams, JJ Ipsaro, J Cahn, J Lynn, HS Kim, B Berube, ... bioRxiv, 2023 | 1 | 2023 |
Clr4SUV39H1ubiquitination and non-coding RNA mediate transcriptional silencing via heterochromatic phase transitions H Kim, B Roche, S Bhattacharjee, L Todeschini, A Chang, C Hammell, ... | | 2021 |
Clr4SUV39H1 and Bdf2BRD4 ubiquitination mediate transcriptional silencing via heterochromatic phase transitions HS Kim, B Roche, S Bhattacharjee, L Todeschini, AY Chang, C Hammell, ... bioRxiv, 2021.01. 08.425919, 2021 | | 2021 |
The role of Fml1 and its partner proteins Mhf1 and Mhf2 in promoting genome stability S Bhattacharjee University of Oxford, 2012 | | 2012 |
Volume 226, Numbers l-4 J Acker, DE Adams, S Adhya, H Ago, SI Aizawa, K Akasaka, AE Aleshin, ... | | |